You are unable to access product pages.

Welcome to EKO Labs USA

Some products offered by EKO Labs USA may be FDA-approved products supplied through licensed laboratory channels, while other products are intended for laboratory research use only.

By entering this website, you confirm that you are at least 21 years old, understand that product eligibility depends on regulatory status and professional verification, and agree to follow all applicable laws and requirements.

By clicking “I Agree,” you confirm:

  • You are at least 21 years of age.
  • You understand product access may depend on product category, regulatory status, and professional verification.
  • You agree to follow all applicable laws and requirements.
  • You understand EKO Labs USA does not provide medical advice, diagnosis, treatment recommendations, dosage guidance, or patient-specific instructions through this website.

Cagrisema

5 mg Purity > 99.5%
CagriSema is a next-generation dual compound therapy combining cagrilintide (amylin analog) and semaglutide (GLP-1 receptor agonist) to support weight loss and metabolic health. It reduces appetite, slows gastric emptying, and improves insulin sensitivity, promoting significant fat reduction and overall metabolic balance.
not a health supplement
not for oral consumption.

Description

CagriSema is a research compound combination that integrates cagrilintide (an amylin analog) and semaglutide (a GLP-1 receptor agonist), commonly studied for its effects on appetite regulation and metabolic function. It is widely used in laboratory and clinical research focused on obesity, glucose control, and energy balance.Researchers are exploring CagriSema for its dual-pathway activity in reducing appetite, slowing gastric emptying, and improving insulin sensitivity. It is frequently studied in models related to visceral fat reduction, body composition changes, and broader metabolic syndrome markers such as lipid and glucose regulation.This product is intended strictly for laboratory and research use only. It is not approved for human consumption, medical treatment, or therapeutic application, and should only be handled by qualified professionals.

Dual Appetite Control

Combines amylin and GLP-1 pathways to curb hunger and enhance satiety.

Rapid Fat Reduction

Targets visceral fat loss while helping preserve lean muscle mass.

Metabolic Optimization

Improves glucose control, lipid profiles, and insulin sensitivity.

Benefits

Boost your confidence and feel energized every day.

Powerful Weight Loss

Reduces appetite and slows gastric emptying, leading to significant body fat and weight reduction in clinical studies.

Comprehensive Metabolic Regulation

Improves HbA1c, insulin sensitivity, blood lipids, and blood pressure for full metabolic syndrome support.

Body Composition Improvement

Promotes fat loss while preserving lean muscle mass, supporting healthier long-term metabolic balance.

Cardiovascular & Glucose Benefits

Supports reductions in blood pressure and improves glycemic control, aiding diabetes and heart health markers.

Frequently Asked
Questions 

How does CagriSema work?
It combines amylin and GLP-1 pathways to reduce appetite, slow gastric emptying, and enhance satiety.
Yes, dual action in trials showed greater weight and fat loss than GLP-1 monotherapy.
Improves HbA1c, insulin sensitivity, triglycerides, LDL-C, and blood pressure.
Mainly gastrointestinal: nausea, vomiting, and mild diarrhea, typically temporary.
Adults with obesity or type 2 diabetes seeking compound-based metabolic therapy.
It’s investigational and in Phase 3 trials; not yet approved for clinical use.

Frequently Asked
Questions 

Why do I need an account to purchase?

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.